Royal seal of approval for Whaley Bridge company Retrogenix

Staff at Retrogenix celebrate receiving the prestigious Queen's Award.
Staff at Retrogenix celebrate receiving the prestigious Queen's Award.

A Whaley Bridge company has won a prestigious award in recognition of a major development.

The Queen’s Award for Innovation, which is made each year by Her Majesty the Queen, is the UK’s most prestigious acknowledgement of business performance, requiring the highest levels of excellence to be demonstrated in each category.

Retrogenix, a biotechnology company based on the Bingswood Industrial Estate, has developed a new technology which is saving millions of pounds in research costs.

Dr Jim Freeth, Managing Director of Retrogenix, said: “It is an honour to receive the Queen’s Award for Innovation.

“The novel approach and high success rate of our human cell microarray technology has allowed us to develop great working relationships with many of the world’s major pharmaceutical companies and leading academic groups, advancing their research and development and supporting breakthroughs in medical research and pharmaceutical discovery.”

And the company’s Executive Director, Jo Soden added: “We have a fantastic team here at Retrogenix and we continue to expand the company and invest in innovation in order to further increase the value of our technology.”

The co-founders of Retrogenix will now attend a reception to meet the Queen at Buckingham Palace in July.

And the award will be formally presented to the company later in the year by a royal representative, the Lord Lieutenant of Derbyshire.